Acute Lymphoblastic Leukemia — Trials

Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

2,037 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 546
Recruiting: 330
Ph III recruiting: 26
Growth YoY: −10%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (268)

clinicaltrialsPublishedShowing 1–26 of 26 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07570173	A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)	recruiting	Phase 2 / Phase 3	340	Merck Sharp & Dohme LLCINDUSTRY	8	Sep 25, 2026	clinicaltrials
NCT07223021	A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia	recruiting	Phase 3	130	Memorial Sloan Kettering Cancer CenterOTHER	2	Sep 17, 2026	clinicaltrials